Tekturna for hypertension

The FDA has approved Tekturna (aliskiren tablets, from Novartis), a once-daily oral medication for the treatment of hypertension as monotherapy or in combination with other antihypertensive agents. In clinical trials, this direct renin inhibitor demonstrated significant blood pressure reductions for a full 24 hours. Tekturna is expected to be available in March 2007 as 150mg and 300mg tablets.

For more information call (888) TEKTURNA or visit www.tekturna.com.

Loading links....
You must be a registered member of Clinical Advisor to post a comment.

2016 Upcoming Meetings

MAY 15-19, 2017 
AAPA 2017
Las Vegas, NV

Click here to view the full calendar

Sign Up for Free e-newsletters